A Prospective Cohort Study of IRPF in China
A Prospective Cohort Study of Idiopathic Retroperitoneal Fibrosis in China
Peking Union Medical College Hospital
500 participants
Jan 17, 2020
OBSERVATIONAL
Conditions
Summary
This is a cohort study to investigate the disease course and treatment response of patients with idiopathic retroperitoneal fibrosis（IRPF）. Methods: All the patients fulfilling diagnostic criteria of IRPF would be enrolled around China. A online database system will been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IRPF patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.
Eligibility
Inclusion Criteria1
- Males and females; 18-75 years old with informed consent; Patients diagnosed with definite or possible IRPF.
Exclusion Criteria1
- Secondary forms of IRPF; Pregnant or Females planning to bear a child recently ; Concurrent severe and/or uncontrolled and/or unstable diseases; Patients with malignancy.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04312854